Strides Pharma Science Limited has announced the appointment of Mr. Biren Gabhawala as a Non-Executive Independent Director, effective November 1, 2026. Mr. Gabhawala brings over three decades of experience in finance, accounting, audit, and corporate governance, having served on the boards of various listed companies. His expertise is expected to enhance the board’s oversight capabilities, internal controls, and risk management.
Strides Pharma Science Strengthens Board
Strides Pharma Science Limited announced today the approval of Mr. Biren Gabhawala’s appointment as a Non-Executive Independent Director. This strategic appointment will be effective from November 1, 2026, and is a key part of the company’s planned board succession initiatives.
Expertise and Experience
Mr. Gabhawala (DIN: 03091772) is a seasoned Chartered Accountant with more than three decades of comprehensive experience across finance, accounting, audit, taxation, corporate finance, and regulatory matters. His professional background includes significant roles in financial reporting and corporate governance. He has previously served on the boards and committees of several listed companies, bringing a wealth of knowledge in financial oversight and risk management.
Board Contribution
The company anticipates that Mr. Gabhawala’s extensive experience will be instrumental in strengthening the Board’s capabilities in areas such as financial oversight, internal controls, risk management, and overall corporate governance. His appointment is for a term of five years, and he is not liable to retire by rotation, subject to shareholder approval.
Source: BSE
